盐霉素钠纳米脂质体的制备及表征

巩志荣; 何文婷; 孙治国; 郭海霞; 钟延强; 鲁莹

doi:10.3969/j.issn.1006-0111.2015.01.009

盐霉素钠纳米脂质体的制备及表征

doi: 10.3969/j.issn.1006-0111.2015.01.009

1.
第二军医大学药学院, 上海 200433
2.
解放军266医院, 河北承德 067000

Preparation and characterization of salinomycin sodium loaded nano liposomes

1.
School of Pharmacy, Second Military Medical University, Shanghai 200433, China
2.
No.266 Hospital of PLA, Chengde 067000, China

摘要: 目的制备并表征盐霉素钠纳米脂质体(SLN)。方法采用薄膜分散法制备盐霉素钠纳米脂质体,通过调节脂质体中胆固醇比例,以盐霉素钠包封率为评价指标,筛选盐霉素钠纳米脂质体的优化处方。结果透射电镜显示盐霉素钠纳米脂质体形态圆整,分散性良好,激光粒度仪显示盐霉素钠纳米脂质体平均粒径为99.0 nm,Zeta电位为-33.5 mV,包封率为85.7%,载药量为6.7%。通过脂质体包裹,盐霉素钠在水中的最高浓度可提高15倍,并证明其具有一定缓释效果。结论笔者得到了粒径大小在100 nm左右,形态均一,包封率和载药量较高的盐霉素钠纳米脂质体,为进一步测定其杀伤肿瘤活性奠定了坚实的制剂学基础。
- 肿瘤干细胞 /
- 盐霉素钠 /
- 脂质体 /
- 包封率 /
- 处方优化
Abstract: Objective To prepare and characterize salinomycin sodium-loaded nano liposomes(SLN). Methods The nano liposomes were prepared by a thin-film dispersion method.The formula of SLN was optimized by regulating the cholesterol ratio of the nano liposomes,using the encapsulation efficacy (EE) of SLN as the primary outcome measure. Results Transmission electron microscope (TEM) showed that SLN was round and had a good dispersion.Dynamic laser scatter (DLS) showed that SLN was of a desired size of 99 nm,and zeta potential of -33.5 mV.EE of SLN was 85.7% and drug loading of 6.7%.According to the formulation of nano liposomes,the concentration of salinomycin sodium in water was greatly improved by 15 folds.Additionally,the nano liposomes were observed to exhibit sustained release characteristics. Conclusion Salinomycin sodium-loaded nanoliposomes of a desired size of about 100 nm were obtained,which were well dispersion,and high EE and drug loading.Solid pharmaceutics foundation for the activity examination of SLN was provided in this research.
- cancer stem cells /
- salinomycin sodium /
- liposomes /
- entrapment efficiency /
- optimization of preparation

[1]	Reya T,Morrison SJ,Clarke MF,et al.Stem cells,cancer,and cancer stem cells[J].Nature,2001,414(6859):105-111. [2] Dean M,Fojo T,Bates S.Tumour stem cells and drug resistance[J].Nat Rev Cancer,2005,5(4):275-284. [3] Gupta PB,Onder TT,Jiang G,et al.Identification of selective inhibitors of cancer stem cells by high-throughput screening[J].Cell,2009,138(4):645-659. [4] Naujokat C,Steinhart R.Salinomycin as a drug for targeting human cancer stem cells[J].Biomed Res Int,2012,2012:1-17. [5] Huczynski A.Salinomycin:a new cancer drug candidate[J].Chem Biol Drug Des,2012,79(3):235-238. [6] Liu Y,Miyoshi H,Nakamura M.Nanomedicine for drug delivery and imaging:a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles[J].Int J Cancer,2007,120(12):2527-2537. [7] Chang H,Yeh M.Clinical development of liposome-based drugs:formulation,characterization,and therapeutic efficacy[J].Int J Nanomed,2012,7:49-60. [8] Barenholz YC.Doxil -the first FDA-approved nano-drug:lessons learned[J].J Control Release,2012,160(2):117-134. [9] Farokhzad OC,Langer R.Nanomedicine:developing smarter therapeutic and diagnostic modalities[J].Adv Drug Deliver Rev,2006,58(14):1456-1459.
[2]	Mayer LD,Hope MJ,Cullis PR.Vesicles of variable sizes produced by a rapid extrusion procedure[J].BBA-Biomembranes 1986,858(1):161-168.
[3]	Mayer LD,Harasym TO,Tardi PG,et al.Ratiometric dosing of anticancer drug combinations:controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice[J].Mol Cancer Ther,2006,5(7):1854-1863.
[4]	Damen J,Regts J,Scherphof G.Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins Dependence on cholesterol content and phospholipid composition[J].Biochim Biophys Acta,1981,665(3):538-545.
[5]	朱会琴, 逄涣欢,胡昌勤,等.浊度法测定两性霉素B及其脂质体的效价[J].中国抗生素杂志,2006,30(12):752-755.
[6]	Wong M,Chiu GN.Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment[J].Anticancer Drugs,2010,21(4):401-410.
[7]	Lasic DD,Woodle MC,Martin FJ,et al.Phase-behavior of stealth-lipid-lecithin mixtures[J].Period Biol,1991,93(2):287-290.
[8]	Dusi G,Gamba V.Liquid chromatography with ultraviolet detection of lasalocid,monensin,salinomycin and narasin in poultry feeds using pre-column derivatization[J].J Chromatogr A,1999,835(1-2):243-246.

[1]	杨金润, 黎翔, 孙旸. ORM1促肝细胞增殖的作用及其机制探索 . 药学实践与服务, 2025, 43(5): 222-227. doi: 10.12206/j.issn.2097-2024.202410014
[2]	陈明, 王晨佳, 唐原君, 汪硕闻, 范国荣. 新型靶向抗肿瘤药物呋喹替尼的治疗药物监测方法构建及其临床应用 . 药学实践与服务, 2025, 43(12): 1-4. doi: 10.12206/j.issn.2097-2024.202412043
[3]	柯刚, 董清科, 肖世容, 龚茜, 李荣, 汪代杰. 基于网络药理学探讨参苓白术散治疗肿瘤恶病质的作用机制 . 药学实践与服务, 2025, 43(5): 242-250. doi: 10.12206/j.issn.2097-2024.202208115
[4]	施乔, 韩贵焱, 张俊腾, 刘娜. 新型Hsp90抑制剂的设计合成及其抗真菌和抗肿瘤活性研究 . 药学实践与服务, 2025, 43(3): 124-135. doi: 10.12206/j.issn.2097-2024.202501019
[5]	吴若南, 汤文敏, 高林, 吴岳林, 罗川, 缪震元. RRx-001衍生物的合成和抗肿瘤活性研究 . 药学实践与服务, 2025, 43(8): 400-403. doi: 10.12206/j.issn.2097-2024.202408053
[6]	周娇, 郑建雨, 王思真, 杨峰. mRNA肿瘤疫苗非病毒递送系统研究进展 . 药学实践与服务, 2025, 43(3): 109-116. doi: 10.12206/j.issn.2097-2024.202410034
[7]	崔亚玲, 吴琼, 马良煜, 胡北, 姚东, 许子华. 肝素钠肌醇烟酸酯乳膏中肌醇烟酸酯皮肤药动学研究 . 药学实践与服务, 2025, 43(1): 6-9, 21. doi: 10.12206/j.issn.2097-2024.202404006
[8]	宋天豪, 许维恒, 王彦, 陈莉. 肝癌肿瘤微环境的研究进展 . 药学实践与服务, 2025, 43(): 1-6. doi: 10.12206/j.issn.2097-2024.202504126
[9]	黄欣, 杨茹洁, 秦峰, 张士莲, 吴莘, 尹小燕. 硫酸镁钠钾口服液在内镜肠道清洁准备中的效果 . 药学实践与服务, 2025, 43(): 1-4. doi: 10.12206/j.issn.2097-2024.202311049
[10]	韦薇, 张明霞, 周艳萍, 颜岚, 田鹏, 冯霞. 基于失效模式与效应分析优化静脉用药调配中心全流程质量控制体系 . 药学实践与服务, 2025, 43(): 1-7. doi: 10.12206/j.issn.2097-2024.202504131
[11]	肖农, 陆诗依, 唐文雅, 居敏俐, 徐刚锋, 杨明华. 中成药微生物计数法前处理的影响因素和优化方法 . 药学实践与服务, 2025, 43(8): 373-376, 409. doi: 10.12206/j.issn.2097-2024.202403014
[12]	陈方剑, 赵娟娟, 叶侃倜, 孙煜昕, 刘继勇, 杨骏. 血通胶囊提取工艺优化及质量控制研究 . 药学实践与服务, 2025, 43(2): 82-86, 91. doi: 10.12206/j.issn.2097-2024.202409003
[13]	杨贺英, 罗彩萍, 彭婷, 梁文仪, 沈颂章, 苏娟. 花椒生物碱富集纯化工艺优化及其成分分析 . 药学实践与服务, 2025, 43(2): 75-81. doi: 10.12206/j.issn.2097-2024.202404066
[14]	钟玲, 曹金发, 何苗, 田泾. 晚期胃癌患者紫杉醇脂质体简化口服预处理方案的实践及分析 . 药学实践与服务, 2025, 43(): 1-4. doi: 10.12206/j.issn.2097-2024.202406047
[15]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架治疗创伤性脑损伤的研究 . 药学实践与服务, 2025, 43(2): 67-74. doi: 10.12206/j.issn.2097-2024.202406034
[16]	刘安泽, 何盈盈, 王欢, 鲁莹. 基于天然IgM新型佐剂的叶酸脂质体疫苗制备及评价 . 药学实践与服务, 2025, 43(11): 555-559. doi: 10.12206/j.issn.2097-2024.202401060
[17]	陈春娟, 郑志新, 李骊. 平喘方联合孟鲁司特钠治疗儿童支气管哮喘的临床疗效观察 . 药学实践与服务, 2024, 42(12): 524-527, 532. doi: 10.12206/j.issn.2097-2024.202405035
[18]	史生辉, 石飞, 雷琼, 王亚峰, 吴雪花. 青藏高原肺结核合并念珠菌感染患者的病原菌分布特点及耐药率分析 . 药学实践与服务, 2024, 42(6): 260-262, 272. doi: 10.12206/j.issn.2097-2024.202304014
[19]	凯丽比努尔·奥布力艾散, 李倩, 谢志, 贾文彦, 尹东锋. 星点设计-效应面法优化仑伐替尼混合胶束的制备工艺 . 药学实践与服务, 2024, 42(11): 495-502. doi: 10.12206/j.issn.2097-2024.202403019
[20]	陈炳辰, 王思真, 郭贝贝, 杨峰. 紫杉醇棕榈酸酯的合成及其脂质体的制备与处方研究 . 药学实践与服务, 2024, 42(9): 379-384, 410. doi: 10.12206/j.issn.2097-2024.202404062

点击查看大图

计量

文章访问数: 4684
HTML全文浏览量: 346
PDF下载量: 260
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

盐霉素钠纳米脂质体的制备及表征

doi: 10.3969/j.issn.1006-0111.2015.01.009

Preparation and characterization of salinomycin sodium loaded nano liposomes

计量

盐霉素钠纳米脂质体的制备及表征

doi: 10.3969/j.issn.1006-0111.2015.01.009

1. 第二军医大学药学院, 上海 200433

2. 解放军266医院, 河北承德 067000

English Abstract

Preparation and characterization of salinomycin sodium loaded nano liposomes

1. School of Pharmacy, Second Military Medical University, Shanghai 200433, China

2. No.266 Hospital of PLA, Chengde 067000, China

全文HTML

目录

留言板

盐霉素钠纳米脂质体的制备及表征

doi: 10.3969/j.issn.1006-0111.2015.01.009

Preparation and characterization of salinomycin sodium loaded nano liposomes

计量

出版历程

盐霉素钠纳米脂质体的制备及表征

doi: 10.3969/j.issn.1006-0111.2015.01.009

1. 第二军医大学药学院, 上海 200433 2. 解放军266医院, 河北 承德 067000

English Abstract

Preparation and characterization of salinomycin sodium loaded nano liposomes

1. School of Pharmacy, Second Military Medical University, Shanghai 200433, China 2. No.266 Hospital of PLA, Chengde 067000, China

全文HTML

目录

1. 第二军医大学药学院, 上海 200433

2. 解放军266医院, 河北承德 067000

1. School of Pharmacy, Second Military Medical University, Shanghai 200433, China

2. No.266 Hospital of PLA, Chengde 067000, China